Idiopathic inflammatory myopathies: new therapeutic horizons

ARP Rheumatology · Published 2026-06-29 · DOI 10.63032/vpzw9778

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.63032/vpzw9778

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Is the association between Immunoglobulin A Nephropathy and Spondyloarthritis real? A case-based review · ARP Rheumatology · 2025 · Same journal
• A pediatric CAPS patient with an unusual presentation and resistance to standard treatment · ARP Rheumatology · 2026 · Same journal
• Prevalence and risk factors of interstitial lung disease in early systemic sclerosis and systemic sclerosis sine scleroderma: a cross-sectional study · ARP Rheumatology · 2025 · Same journal
• Disease activity in systemic lupus erythematosus in relation to direct Coombs test positivity without haemolytic anaemia: a single-centre cross-sectional study · ARP Rheumatology · 2026 · Same journal
• Vanishing hips: unveiling Gorham-Stout syndrome · ARP Rheumatology · 2025 · Same journal
• Translation and cross-cultural adaptation of the mSQUASH into European Portuguese · ARP Rheumatology · 2025 · Same journal
• Reliability and validity of the European Portuguese version of the ABILHAND questionnaire in Patients with Systemic Sclerosis · ARP Rheumatology · 2025 · Same journal
• Bilateral parotid gland swelling unveiling non-Hodgkin lymphoma · ARP Rheumatology · 2025 · Same journal
• Subclinical right ventricular dysfunction in juvenile systemic sclerosis: a cross-sectional echocardiographic study · ARP Rheumatology · 2025 · Same journal
• Points to consider for patient education provided by nurses on methotrexate use. A European consensus initiative · ARP Rheumatology · 2026 · Same journal